FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Makoto Nakamuta

Research Profile

Anatomy

Disorders

Living Beings

Chemicals & Drugs

Procedures

Reverse Transcriptase Polymerase Chain Reaction

Concepts & Ideas

Time Factors

Co-author Network

Publications

TOP 3
Masatake Tanaka; Kosuke Tanaka; Shinichi Aishima; Munechika Enjoji; Masaki Kato; Kazuhiro Kotoh; Yuko Masaki; Masayuki Miyazaki; Kazuhiko Nakamura; Makoto Nakamuta; Ken Shirabe; Rie Sugimoto; Ryoichi Takayanagi
Reduction of fatty acid oxidation and responses to hypoxia correlate with the progression of de-differentiation in HCC.
Motoyuki Kohjima; Kazuhiro Kotoh; Yoko Aoyagi; Munechika Enjoji; Tatsuya Fujino; Kunitaka Fukuizumi; Nobuyoshi Fukushima; Naohiko Harada; Masaki Kato; Manabu Nakashima; Naoya Sakamoto; Yasuhito Tanaka; Masayoshi Yada; Ryoko Yada; Tsuyoshi Yoshimoto; Makoto Nakamuta
Add-on therapy of pitavastatin and eicosapentaenoic acid improves outcome of peginterferon plus ribavirin treatment for chronic hepatitis C.
Kana Kakigao; Ken Kawabe; Motoyuki Koujima; Aya Mitsuyasu; Takahiro Mizutani; Makoto Nakamuta; Risa Okamoto; Tomoko Oohashi; Noriko Sawamura; Tsuyoshi Yoshimoto; Takashi Fujiyama; Kunitaka Fukuizumi; Nobuyoshi Fukushima; Kazuhiro Haraguchi; Naohiko Harada
[A case of protein-losing gastroenteropathy accompanied by Sjögren syndrome and mixed connective tissue disease].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Makoto Nakamuta (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Masatake Tanaka; Kosuke Tanaka; Shinichi Aishima; Munechika Enjoji; Masaki Kato; Kazuhiro Kotoh; Yuko Masaki; Masayuki Miyazaki; Kazuhiko Nakamura; Makoto Nakamuta; Ken Shirabe; Rie Sugimoto; Ryoichi Takayanagi
Reduction of fatty acid oxidation and responses to hypoxia correlate with the progression of de-differentiation in HCC.
Molecular medicine reports 2013;7(2):365-70.
2013: Motoyuki Kohjima; Kazuhiro Kotoh; Yoko Aoyagi; Munechika Enjoji; Tatsuya Fujino; Kunitaka Fukuizumi; Nobuyoshi Fukushima; Naohiko Harada; Masaki Kato; Manabu Nakashima; Naoya Sakamoto; Yasuhito Tanaka; Masayoshi Yada; Ryoko Yada; Tsuyoshi Yoshimoto; Makoto Nakamuta
Add-on therapy of pitavastatin and eicosapentaenoic acid improves outcome of peginterferon plus ribavirin treatment for chronic hepatitis C.
Journal of medical virology 2013;85(2):250-60.
2012: Kana Kakigao; Ken Kawabe; Motoyuki Koujima; Aya Mitsuyasu; Takahiro Mizutani; Makoto Nakamuta; Risa Okamoto; Tomoko Oohashi; Noriko Sawamura; Tsuyoshi Yoshimoto; Takashi Fujiyama; Kunitaka Fukuizumi; Nobuyoshi Fukushima; Kazuhiro Haraguchi; Naohiko Harada
[A case of protein-losing gastroenteropathy accompanied by Sjögren syndrome and mixed connective tissue disease].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 2012;109(10):1770-5.
2012: Masayuki Miyazaki; Makoto Nakamuta; Shinichiro Takao; Munechika Enjoji; Tetsuhide Ito; Masaki Kato; Motoyuki Kohjima; Kazuhiro Kotoh; Kosuke Tanaka; Masatake Tanaka; Ryoichi Takayanagi
Antithrombin III injection via the portal vein suppresses liver damage.
World journal of gastroenterology : WJG 2012;18(16):1884-91.
2012: Noriko Sawamura; Makiko Sugi; Tsuyoshi Yoshimoto; Rie Yoshimura; Makoto Nakamuta; Kunitaka Fukuizumi; Nobuyoshi Fukushima; Naohiko Harada; Kazuhiro Haraguchi; Eikichi Ihara; Kana Kakigao; Ken Kawabe; Takahiro Mizutani; Kazuhiko Nakamura
[A case of Cowden disease with a germline mutation in exon5 of PTEN gene diagnosed based on typical esophageal multiple polypoid lesions observed on a medical checkup].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 2012;109(4):593-9.
2012: Kenichiro Yasutake; Motoyuki Kohjima; Kazuhiro Kotoh; Makoto Nakamuta; Manabu Nakashima; Munechika Enjoji
Nutrition therapy for liver diseases based on the status of nutritional intake.
Gastroenterology research and practice 2012;2012():859697.
2012: Kenichiro Yasutake; Machiko Bekki; Tatsuya Fujino; Kunitaka Fukuizumi; Masako Ichinose; Michiko Ikemoto; Motoyuki Kohjima; Makoto Nakamuta; Manabu Nakashima; Tomoki Ryu; Hideki Saitsu; Yuko Takami; Yoshiyuki Wada; Munechika Enjoji
Assessing current nutritional status of patients with HCV-related liver cirrhosis in the compensated stage.
Asia Pacific journal of clinical nutrition 2012;21(3):400-5.
2012: Munechika Enjoji; Motoyuki Kohjima; Kazuhiro Kotoh; Makoto Nakamuta
Metabolic disorders and steatosis in patients with chronic hepatitis C: metabolic strategies for antiviral treatments.
International journal of hepatology 2012;2012():264017.
2012: Munechika Enjoji; Motoyuki Kohjima; Kenichiro Yasutake; Makoto Nakamuta
Nutrition and nonalcoholic Fatty liver disease: the significance of cholesterol.
International journal of hepatology 2012;2012():925807.
2011: Tatsuya Fujino; Mika Fukuda; Hiromi Ishibashi; Motoyuki Kohjima; Makoto Nakamuta; Takeaki Satoh; Hiroshi Yatsuhashi; Yoko Aoyagi; Munechika Enjoji
Early dynamics of viremia in patients with genotype 1b chronic hepatitis C: Peg-IFNalpha2a shows earlier viral decline than peg-IFNalpha2b in combination therapy with ribavirin.
Medical science monitor : international medical journal of experimental and clinical research 2011;17(12):CR687-91.
2011: Masayuki Miyazaki; Makoto Nakamuta; Shinichiro Takao; Munechika Enjoji; Tetsuhide Ito; Masaki Kato; Motoyuki Kohjima; Kazuhiro Kotoh; Kosuke Tanaka; Masatake Tanaka; Ryoichi Takayanagi
Contrast-enhanced ultrasonography using Sonazoid to evaluate changes in hepatic hemodynamics in acute liver injury.
Journal of gastroenterology and hepatology 2011;26(12):1749-56.
2011: Yoshihiro Aiba; Nobuyoshi Fukushima; Shigeki Hayashi; Hitomi Horie; Tatsuo Inamine; Hiromi Ishibashi; Satoru Joshita; Michiaki Koga; Tatsuji Komatsu; Toshiki Komeda; Atsumasa Komori; Hiroshi Kouno; Naohiko Masaki; Kiyoshi Migita; Toyokichi Muro; Minoru Nakamura; Yoko Nakamura; Makoto Nakamuta; Hajime Ota; Takeo Saoshiro; Masaaki Shimada; Kazuhiro Sugi; Eiji Tanaka; Kazuhiro Tsukamoto; Takeji Umemura; Yukio Watanabe; Michiyasu Yagura; Hiroshi Yatsuhashi; Kaname Yoshizawa
Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients.
Journal of gastroenterology 2011;46(10):1203-12.
2011: Makoto Nakamuta; T Fujino; R Yada; Y Aoyagi; K Yasutake; Motoyuki Kohjima; Kunitaka Fukuizumi; Tsuyoshi Yoshimoto; Naohiko Harada; M Yada; Masaki Kato; Kazuhiro Kotoh; Akinobu Taketomi; Yoshihiko Maehara; M Nakashima; Munechika Enjoji
Expression profiles of genes associated with viral entry in HCV-infected human liver.
Journal of medical virology 2011;83(5):921-7.
2011: Mako Toyoda; Akira Kitaoka; Kazuyuki Machida; Takuya Nishinakagawa; Ryoko Yada; Motoyuki Kohjima; Masaki Kato; Kazuhiro Kotoh; Naoya Sakamoto; Goshi Shiota; Makoto Nakamuta; Manabu Nakashima; Munechika Enjoji
Association between lipid accumulation and the cannabinoid system in Huh7 cells expressing HCV genes.
International journal of molecular medicine 2011;27(5):619-24.
2011: Nobito Higuchi; Masaki Kato; Masayuki Miyazaki; Masatake Tanaka; Motoyuki Kohjima; Tetsuhide Ito; Makoto Nakamuta; Munechika Enjoji; Kazuhiro Kotoh; Ryoichi Takayanagi
Potential role of branched-chain amino acids in glucose metabolism through the accelerated induction of the glucose-sensing apparatus in the liver.
Journal of cellular biochemistry 2011;112(1):30-8.
2010: Tatsuya Fujino; Makoto Nakamuta; Ryoko Yada; Yoko Aoyagi; Kenichiro Yasutake; Motoyuki Kohjima; Kunitaka Fukuizumi; Tsuyoshi Yoshimoto; Naohiko Harada; Masayoshi Yada; Masaki Kato; Kazuhiro Kotoh; Akinobu Taketomi; Yoshihiko Maehara; Manabu Nakashima; Munechika Enjoji
Expression profile of lipid metabolism-associated genes in hepatitis C virus-infected human liver.
Hepatology research : the official journal of the Japan Society of Hepatology 2010;40(9):923-9.
2010: Munechika Enjoji; Kazuyuki Machida; Motoyuki Kohjima; Masaki Kato; Kazuhiro Kotoh; Kazuhisa Matsunaga; Manabu Nakashima; Makoto Nakamuta
NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease.
Lipids in health and disease 2010;9():29.
2009: Makoto Nakamuta; Ryoko Yada; Tatsuya Fujino; Masayoshi Yada; Nobito Higuchi; Masatake Tanaka; Masayuki Miyazaki; Motoyuki Kohjima; Masaki Kato; Tsuyoshi Yoshimoto; Naohiko Harada; Akinobu Taketomi; Yoshihiko Maehara; Momoko Koga; Takuya Nishinakagawa; Manabu Nakashima; Kazuhiro Kotoh; Munechika Enjoji
Changes in the expression of cholesterol metabolism-associated genes in HCV-infected liver: a novel target for therapy?
International journal of molecular medicine 2009;24(6):825-8.
2009: Munechika Enjoji; Tatsuya Fujino; Naohiko Harada; Nobito Higuchi; Masaki Kato; Motoyuki Kohjima; Kazuhiro Kotoh; Yoshihiko Maehara; Manabu Nakashima; Akinobu Taketomi; Masayoshi Yada; Ryoko Yada; Tsuyoshi Yoshimoto; Makoto Nakamuta
The state of cholesterol metabolism in the liver of patients with primary biliary cirrhosis: the role of MDR3 expression.
Hepatology international 2009;3(3):490-6.
2009: Ryosuke Takemoto; Makoto Nakamuta; Yoko Aoyagi; Tatsuya Fujino; Kenichiro Yasutake; Kotaro Koga; Tsuyoshi Yoshimoto; Toshihiko Miyahara; Kunitaka Fukuizumi; Yoshiyuki Wada; Yuko Takami; Hideki Saitsu; Naohiko Harada; Manabu Nakashima; Munechika Enjoji
Validity of FibroScan values for predicting hepatic fibrosis stage in patients with chronic HCV infection.
Journal of digestive diseases 2009;10(2):145-8.
2009: Makoto Nakamuta; Tatsuya Fujino; Ryoko Yada; Masayoshi Yada; Kenichiro Yasutake; Tsuyoshi Yoshimoto; Naohiko Harada; Nobito Higuchi; Masaki Kato; Motoyuki Kohjima; Akinobu Taketomi; Yoshihiko Maehara; Manabu Nakashima; Kazuhiro Kotoh; Munechika Enjoji
Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease.
International journal of molecular medicine 2009;23(5):603-8.
2009: Tatsuya Fujino; Makoto Nakamuta; Yoko Aoyagi; Kunitaka Fukuizumi; Ryosuke Takemoto; Tsuyoshi Yoshimoto; Toshihiko Miyahara; Naohiko Harada; Hironori Sakai; Manabu Nakashima; Munechika Enjoji
Early decline of the HCV core antigen can predict SVR in patients with HCV treated by Pegylated interferon plus ribavirin combination therapy.
Journal of digestive diseases 2009;10(1):21-5.
2009: Kenichiro Yasutake; Makoto Nakamuta; Yuki Shima; Akiko Ohyama; Kaori Masuda; Noriko Haruta; Tatsuya Fujino; Yoko Aoyagi; Kunitaka Fukuizumi; Tsuyoshi Yoshimoto; Ryosuke Takemoto; Toshihiko Miyahara; Naohiko Harada; Fukuko Hayata; Manabu Nakashima; Munechika Enjoji
Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.
Scandinavian journal of gastroenterology 2009;44(4):471-7.
2009: Motoyuki Kohjima; Munechika Enjoji; Nobito Higuchi; Masaki Kato; Kazuhiro Kotoh; Manabu Nakashima; Makoto Nakamuta
The effects of unsaturated fatty acids on lipid metabolism in HepG2 cells.
In vitro cellular & developmental biology. Animal 2009;45(1-2):6-9.
2008: Makoto Nakamuta; Motoyuki Kohjima; Nobito Higuchi; Masaki Kato; Kazuhiro Kotoh; Tsuyoshi Yoshimoto; Masayoshi Yada; Ryoko Yada; Ryosuke Takemoto; Kunitaka Fukuizumi; Naohiko Harada; Akinobu Taketomi; Yoshihiko Maehara; Manabu Nakashima; Munechika Enjoji
The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease.
International journal of molecular medicine 2008;22(5):663-7.
2008: Munechika Enjoji; Kazuhiro Kotoh; Masaki Kato; Nobito Higuchi; Motoyuki Kohjima; Manabu Nakashima; Makoto Nakamuta
Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study.
International journal of molecular medicine 2008;22(4):521-7.
2008: Kengo Yoshimitsu; Yousuke Kuroda; Makoto Nakamuta; Akinobu Taketomi; Hiroyuki Irie; Tsuyoshi Tajima; Masakazu Hirakawa; Kousei Ishigami; Yasuhiro Ushijima; Tomomi Yamada; Hiroshi Honda
Noninvasive estimation of hepatic steatosis using plain CT vs. chemical-shift MR imaging: significance for living donors.
Journal of magnetic resonance imaging : JMRI 2008;28(3):678-84.
2008: Norihiro Furusyo; Eiji Kajiwara; Kazuhiro Takahashi; Hideyuki Nomura; Yuichi Tanabe; Akihide Masumoto; Toshihiro Maruyama; Makoto Nakamuta; Munechika Enjoji; Koichi Azuma; Junya Shimono; Hironori Sakai; Shinji Shimoda; Jun Hayashi
Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: project of the Kyushu University Liver Disease Study Group.
Journal of gastroenterology and hepatology 2008;23(7 Pt 1):1094-104.
2008: Motoyuki Kohjima; Nobito Higuchi; Masaki Kato; Kazuhiro Kotoh; Tsuyoshi Yoshimoto; Tatsuya Fujino; Masayoshi Yada; Ryoko Yada; Naohiko Harada; Munechika Enjoji; Ryoichi Takayanagi; Makoto Nakamuta
SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
International journal of molecular medicine 2008;21(4):507-11.
2008: Naoki Yamashita; Munechika Enjoji; Kazuhiro Kotoh; Masaki Kato; Akihiro Ueda; Yuki Horikawa; Hirotaka Tajiri; Nobito Higuchi; Naoko Kinukawa; Makoto Nakamuta; Ryoichi Takayanagi
Investigation of hyperuricemia during pegylated-interferon-alpha2b plus ribavirin combination therapy in patients with chronic hepatitis C.
Journal of digestive diseases 2008;9(1):27-31.
2008: Kazuhiro Kotoh; Munechika Enjoji; Masaki Kato; Motoyuki Kohjima; Makoto Nakamuta; Ryoichi Takayanagi
A new parameter using serum lactate dehydrogenase and alanine aminotransferase level is useful for predicting the prognosis of patients at an early stage of acute liver injury: a retrospective study.
Comparative hepatology 2008;7():6.
2008: Nobito Higuchi; Masaki Kato; Yuki Shundo; Hirotaka Tajiri; Masatake Tanaka; Naoki Yamashita; Motoyuki Kohjima; Kazuhiro Kotoh; Makoto Nakamuta; Ryoichi Takayanagi; Munechika Enjoji
Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease.
Hepatology research : the official journal of the Japan Society of Hepatology 2008;38(11):1122-9.
2007: Ryuji Yasumatsu; Kenji Okura; Yumiko Sakiyama; Makoto Nakamuta; Taisei Matsumura; Satoru Uehara; Tomoya Yamamoto; Shizuo Komune
Metastatic hepatocellular carcinoma of the external auditory canal.
World journal of gastroenterology : WJG 2007;13(47):6436-8.
2007: Nobito Higuchi; Masaki Kato; Kazuhiro Kotoh; Motoyuki Kohjima; Shinichi Aishima; Makoto Nakamuta; Yoshinori Fukui; Ryoichi Takayanagi; Munechika Enjoji
Methylprednisolone injection via the portal vein suppresses inflammation in acute liver failure induced in rats by lipopolysaccharide and d-galactosamine.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(10):1342-8.
2007: Yuji Soejima; Mitsuo Shimada; Akinobu Taketomi; Tomoharu Yoshizumi; Hideaki Uchiyama; Toru Ikegami; Makoto Nakamuta; Yoshihiko Maehara
Successful living donor liver transplantation using a graft from a hepatitis B surface antigen-positive donor.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(9):1282-6.
2007: Motoyuki Kohjima; Munechika Enjoji; Nobito Higuchi; Kazuhiro Kotoh; Masaki Kato; Ryoichi Takayanagi; Makoto Nakamuta
NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(9):1273-81.
2007: Akihiro Ueda; Munechika Enjoji; Masaki Kato; Naoki Yamashita; Yuki Horikawa; Hirotaka Tajiri; Kazuhiro Kotoh; Makoto Nakamuta; Ryoichi Takayanagi
[Frequency of gastroesophageal reflux disease (GERD) as a complication in patients with chronic liver diseases: estimation of frequency scale for the system of GERD].
Fukuoka igaku zasshi = Hukuoka acta medica 2007;98(10):373-8.
2007: Motoyuki Kohjima; Munechika Enjoji; Nobito Higuchi; Masaki Kato; Kazuhiro Kotoh; Tsuyoshi Yoshimoto; Tatsuya Fujino; Masayoshi Yada; Ryoko Yada; Naohiko Harada; Ryoichi Takayanagi; Makoto Nakamuta
Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
International journal of molecular medicine 2007;20(3):351-8.
2007: Sawako Inoue; Shusuke Morizono; Shinsaku Yamashita; Yuki Horikawa; Motoyuki Kohjima; Yuzuru Miyagi; Tsuyosi Yoshimoto; Kazuhiro Kotoh; Munechika Enjoji; Ryoichi Takayanagi; Yuji Soejima; Akinobu Taketomi; Tomoharu Yoshizumi; Yoshihiko Maehara; Makoto Nakamuta
[Estimation of indication for living donor liver transplantation in patients with HCV and/or HBV infection].
Fukuoka igaku zasshi = Hukuoka acta medica 2007;98(7):295-300.
2007: Tsuyoshi Yoshimoto; Kazuhiro Kotoh; Yuki Horikawa; Motoyuki Kohjima; Shusuke Morizono; Shinsaku Yamashita; Munechika Enjoji; Makoto Nakamuta
Decreased portal flow volume increases the area of necrosis caused by radio frequency ablation in pigs.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(3):368-72.
2007: Makoto Nakamuta; Kazuhiro Kotoh; Munechika Enjoji; Eiji Kajiwara; Junya Shimono; Akihide Masumoto; Toshihiro Maruyama; Norihiro Furusyo; Hideyuki Nomura; Hironori Sakai; Kazuhiro Takahashi; Koichi Azuma; Shinji Shimoda; Yuichi Tanabe; Jun Hayashi
Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients.
Comparative hepatology 2007;6():3.
2007: Kazuhiro Kotoh; Makoto Nakamuta; Marie Fukushima; Shusuke Morizono; Munechika Enjoji; Hajime Nawata
Fertile females with nonalcoholic fatty liver disease (NAFLD) have higher levels of ALT than postmenopausal females: implications for the influence of fertility on NAFLD.
Hepato-gastroenterology 2007;54(73):224-8.
2006: J Hong; Hideaki Nakashima; Kouzou Konishi; Satoshi Ieiri; Kazuo Tanoue; Makoto Nakamuta; Makoto Hashizume
Interventional navigation for abdominal therapy based on simultaneous use of MRI and ultrasound.
Medical & biological engineering & computing 2006;44(12):1127-34.
2006: Kazuhiro Kotoh; Munechika Enjoji; Makoto Nakamuta; Tsuyoshi Yoshimoto; Motoyuki Kohjima; Shusuke Morizono; Shinsaku Yamashita; Yuki Horikawa; Kengo Yoshimitsu; Tsuyoshi Tajima; Yoshiki Asayama; Kousei Ishigami; Masakazu Hirakawa
Arterial steroid injection therapy can inhibit the progression of severe acute hepatic failure toward fulminant liver failure.
World journal of gastroenterology : WJG 2006;12(41):6678-82.
2006: Norihiro Furusyo; Masaki Katoh; Yuichi Tanabe; Eiji Kajiwara; Toshihiro Maruyama; Junya Shimono; Hironori Sakai; Makoto Nakamuta; Hideyuki Nomura; Akihide Masumoto; Shinji Shimoda; Kazuhiro Takahashi; Koichi Azuma; Jun Hayashi
Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: a project of the Kyushu University Liver Disease Study Group.
World journal of gastroenterology : WJG 2006;12(5):784-90.
2006: Munechika Enjoji; Kazuhiro Kotoh; Makoto Nakamuta
[Factors affecting the increase of urinary diacetylspermine levels : a study in patients with liver diseases].
Rinsho byori. The Japanese journal of clinical pathology 2006;54(2):126-31.
2006: Norihiro Furusyo; Hiroaki Takeoka; Kazuhiro Toyoda; Masayuki Murata; Yuichi Tanabe; Eiji Kajiwara; Junya Shimono; Akihide Masumoto; Toshihiro Maruyama; Hideyuki Nomura; Makoto Nakamuta; Kazuhiro Takahashi; Shinji Shimoda; Koichi Azuma; Hironori Sakai; Jun Hayashi
Long-term lamivudine treatment for chronic hepatitis B in Japanese patients: a project of Kyushu University Liver Disease Study.
World journal of gastroenterology : WJG 2006;12(4):561-7.
2006: Makoto Nakamuta; Motoyuki Kohjima; Shusuke Morizono; Tsuyoshi Yoshimoto; Yuzuru Miyagi; Hironori Sakai; Munechika Enjoji; Kazuhiro Kotoh
Comparison of tissue pressure and ablation time between the LeVeen and cool-tip needle methods.
Comparative hepatology 2006;5():10.
2006: Tsuyoshi Yoshimoto; Makoto Nakamuta; Kazuhiro Kotoh; Motoyuki Kohjima; Shusuke Morizono; Yuzuru Miyagi; Hironori Sakai; Munechika Enjoji
An adult case with Hunter's syndrome presenting prominent hepatic failure: light and electron microscopic features of the liver.
Internal medicine (Tokyo, Japan) 2006;45(20):1133-5.
2005: Makoto Nakamuta; Shusuke Morizono; Motoyuki Kohjima; Kazuhiro Kotoh; Munechika Enjoji
Baseline characterization of patients aged 70 years and above with hepatocellular carcinoma.
World journal of gastroenterology : WJG 2005;11(47):7512-4.
2005: Makoto Nakamuta; Motoyuki Kohjima; Marie Fukushima; Shusuke Morizono; Kazuhiro Kotoh; Naoya Kobayashi; Munechika Enjoji
Cyclosporine suppresses cell growth and collagen production in hepatic stellate cells.
Transplantation proceedings 2005;37(10):4598-602.
2005: Kazuhiro Kotoh; Shusuke Morizono; Motoyuki Kohjima; Munechika Enjoji; Hironori Sakai; Makoto Nakamuta
Evaluation of liver parenchymal pressure and portal endothelium damage during radio frequency ablation in an in vivo porcine model.
Liver international : official journal of the International Association for the Study of the Liver 2005;25(6):1217-23.
2005: Makoto Nakamuta; Shusuke Morizono; Yuichi Tanabe; Eiji Kajiwara; Junya Shimono; Akihide Masumoto; Toshihiro Maruyama; Norihiro Furusyo; Hideyuki Nomura; Hironori Sakai; Kazuhiro Takahashi; Koichi Azuma; Shinji Shimoda; Kazuhiro Kotoh; Munechika Enjoji; Jun Hayashi
Relationship between body surface area and ALT normalization after long-term lamivudine treatment.
World journal of gastroenterology : WJG 2005;11(44):6948-53.
2005: Kazuhiro Kotoh; Munechika Enjoji; Eiichirou Arimura; Shusuke Morizono; Motoyuki Kohjima; Hironori Sakai; Makoto Nakamuta
Scattered and rapid intrahepatic recurrences after radio frequency ablation for hepatocellular carcinoma.
World journal of gastroenterology : WJG 2005;11(43):6828-32.
2005: Marie Fukushima; Munechika Enjoji; Motoyuki Kohjima; Rie Sugimoto; Satoshi Ohta; Kazuhiro Kotoh; Masami Kuniyoshi; Kunihisa Kobayashi; Minako Imamura; Toyoshi Inoguchi; Makoto Nakamuta; Hajime Nawata
Adipose differentiation related protein induces lipid accumulation and lipid droplet formation in hepatic stellate cells.
In vitro cellular & developmental biology. Animal 2005;41(10):321-4.
2005: Masaki Kato; Naoya Shimohashi; Jiro Ouchi; Kisaku Yoshida; Yuichi Tanabe; Kenji Takenaka; Makoto Nakamuta
Partial splenic embolization facilitates completion of interferon therapy in patients with chronic HCV infection and hypersplenism.
Journal of gastroenterology 2005;40(11):1076-7.
2005: Satoshi Ohta; Makoto Nakamuta; Marie Fukushima; Motoyuki Kohjima; Kazuhiro Kotoh; Munechika Enjoji; Hajime Nawata
Beraprost sodium, a prostacyclin (PGI) analogue, ameliorates concanavalin A-induced liver injury in mice.
Liver international : official journal of the International Association for the Study of the Liver 2005;25(5):1061-8.
2005: Rie Sugimoto; Munechika Enjoji; Motoyuki Kohjima; Satoru Tsuruta; Marie Fukushima; Masataka Iwao; Toshiyo Sonta; Kazuhiro Kotoh; Toyoshi Inoguchi; Makoto Nakamuta
High glucose stimulates hepatic stellate cells to proliferate and to produce collagen through free radical production and activation of mitogen-activated protein kinase.
Liver international : official journal of the International Association for the Study of the Liver 2005;25(5):1018-26.
2005: Makoto Nakamuta; Nobuhiko Higashi; Motoyuki Kohjima; Marie Fukushima; Satoshi Ohta; Kazuhiro Kotoh; Naoya Kobayashi; Munechika Enjoji
Epigallocatechin-3-gallate, a polyphenol component of green tea, suppresses both collagen production and collagenase activity in hepatic stellate cells.
International journal of molecular medicine 2005;16(4):677-81.
2005: Makoto Nakamuta; Motoyuki Kohjima; Shusuke Morizono; Kazuhiro Kotoh; Tsuyoshi Yoshimoto; Izuru Miyagi; Munechika Enjoji
Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
International journal of molecular medicine 2005;16(4):631-5.
2005: Munechika Enjoji; Shusuke Morizono; Kazuhiro Kotoh; Motoyuki Kohjima; Yuzuru Miyagi; Tsuyoshi Yoshimoto; Makoto Nakamuta
Re-evaluation of antitumor effects of combination chemotherapy with interferon-alpha and 5-fluorouracil for advanced hepatocellular carcinoma.
World journal of gastroenterology : WJG 2005;11(36):5685-7.
2005: Eiichirou Arimura; Kazuhiro Kotoh; Makoto Nakamuta; Shusuke Morizono; Munechika Enjoji; Hajime Nawata
Local recurrence is an important prognostic factor of hepatocellular carcinoma.
World journal of gastroenterology : WJG 2005;11(36):5601-6.
2005: Makoto Nakamuta; Shusuke Morizono; Yuji Soejima; Tomoharau Yoshizumi; Shinichi Aishima; Shin-ichiro Takasugi; Kengo Yoshimitsu; Munechika Enjoji; Kazuhiro Kotoh; Akinobu Taketomi; Hideaki Uchiyama; Mitsuo Shimada; Hajime Nawata; Yoshihiko Maehara
Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation.
Transplantation 2005;80(5):608-12.
2005: Koji Yamaguchi; Munechika Enjoji; Manabu Nakashima; Makoto Nakamuta; Takashi Watanabe; Masao Tanaka
Novel serum tumor marker, RCAS1, in pancreatic diseases.
World journal of gastroenterology : WJG 2005;11(33):5199-202.
2005: Munechika Enjoji; Manabu Nakashima; Koji Yamaguchi; Kazuhiro Kotoh; Makoto Nakamuta
Significance of RCAS1 antigen in hepatocellular, cholangiocellular and pancreatic carcinomas.
Journal of gastroenterology and hepatology 2005;20(8):1143-8.
2005: Marie Fukushima; Makoto Nakamuta; Motoyuki Kohjima; Kazuhiro Kotoh; Munechika Enjoji; Naoya Kobayashi; Hajime Nawata
Fasudil hydrochloride hydrate, a Rho-kinase (ROCK) inhibitor, suppresses collagen production and enhances collagenase activity in hepatic stellate cells.
Liver international : official journal of the International Association for the Study of the Liver 2005;25(4):829-38.
2005: Makoto Nakamuta; Shusuke Morizono; Satoru Tsuruta; Motoyuki Kohjima; Kazuhiro Kotoh; Munechika Enjoji
Remote delivery and expression of soluble type II TGF-beta receptor in muscle prevents hepatic fibrosis in rats.
International journal of molecular medicine 2005;16(1):59-64.
2005: Norihiro Furusyo; Norihiko Kubo; Kazuhiro Toyoda; Hiroaki Takeoka; Shigeki Nabeshima; Masayuki Murata; Makoto Nakamuta; Jun Hayashi
Helper T cell cytokine response to ribavirin priming before combined treatment with interferon alpha and ribavirin for patients with chronic hepatitis C.
Antiviral research 2005;67(1):46-54.
2005: Eiichirou Arimura; Makoto Nakamuta; Kazuhiro Kotoh; Shusuke Morizono; Motoyuki Kohjima; Marie Fukushima; Munechika Enjoji; Hajime Nawata
[A case of idiopathic portal hypertension complicated with sepsis caused by Aeromonas hydrophila].
Fukuoka igaku zasshi = Hukuoka acta medica 2005;96(6):259-64.
2005: Nobuhiko Higashi; Motoyuki Kohjima; Marie Fukushima; Satoshi Ohta; Kazuhiro Kotoh; Munechika Enjoji; Naoya Kobayashi; Makoto Nakamuta
Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Rho signaling in TWNT-4 human hepatic stellate cells.
The Journal of laboratory and clinical medicine 2005;145(6):316-22.
2005: Kazuhiro Kotoh; Makoto Nakamuta; Shusuke Morizono; Motoyuki Kohjima; Eiichirou Arimura; Marie Fukushima; Munechika Enjoji; Hironori Sakai; Hajime Nawata
A multi-step, incremental expansion method for radio frequency ablation: optimization of the procedure to prevent increases in intra-tumor pressure and to reduce the ablation time.
Liver international : official journal of the International Association for the Study of the Liver 2005;25(3):542-7.
2005: Makoto Nakamuta; Munechika Enjoji; Kazuhiro Kotoh; Naoya Shimohashi; Yuichi Tanabe
Long-term fibrate treatment for PBC.
Journal of gastroenterology 2005;40(5):546-7.
2005: Makoto Nakamuta; Kazuhiro Kotoh; Munechika Enjoji; Hajime Nawata
Effects of fibril- or fixed-collagen on matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 production in the human hepatocyte cell line HLE.
World journal of gastroenterology : WJG 2005;11(15):2264-8.
2005: Munechika Enjoji; Eiichirou Arimura; Motoyuki Kohjima; Kazuhiro Kotoh; Makoto Nakamuta
Urinary N',N'2-diacetylspermine levels correlate with HCV amount in patients with chronic hepatitis C.
The International journal of biological markers 2005;20(2):137-8.
2005: Shusuke Morizono; Munechika Enjoji; Noriyuki Sonoda; Marie Fukushima; Masami Kuniyoshi; Kazuhiro Kotoh; Makoto Nakamuta; Hajime Nawata
Lemierre's syndrome: Porphyromonas asaccharolytica as a putative pathogen.
Internal medicine (Tokyo, Japan) 2005;44(4):350-3.
2005: Rie Sugimoto; Munechika Enjoji; Makoto Nakamuta; Satoshi Ohta; Motoyuki Kohjima; Marie Fukushima; Masami Kuniyoshi; Eiichirou Arimura; Shusuke Morizono; Kazuhiro Kotoh; Hajime Nawata
Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells.
Liver international : official journal of the International Association for the Study of the Liver 2005;25(2):420-8.
2005: Kazuhiro Kotoh; Makoto Nakamuta; Marie Fukushima; Chitose Matsuzaki; Munechika Enjoji; Hironori Sakai; Hajime Nawata
High relative fat-free mass is important for maintaining serum albumin levels in patients with compensated liver cirrhosis.
World journal of gastroenterology : WJG 2005;11(9):1356-60.
2005: Munechika Enjoji; Makoto Nakamuta; Koji Yamaguchi; Satoshi Ohta; Kazuhiro Kotoh; Marie Fukushima; Masami Kuniyoshi; Tomomi Yamada; Masao Tanaka; Hajime Nawata
Clinical significance of serum levels of vascular endothelial growth factor and its receptor in biliary disease and carcinoma.
World journal of gastroenterology : WJG 2005;11(8):1167-71.
2005: Marie Fukushima; Kazuhiro Kotoh; Munechika Enjoji; Makoto Nakamuta; Hajime Nawata; Shinichi Aishima
[A case of valproate-associated hyperammonemia with chronic hepatitis C].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 2005;102(1):42-7.
2004: Kazuhiro Kotoh; Makoto Nakamuta; Motoyuki Kohjima; Marie Fukushima; Shusuke Morizono; Naoya Kobayashi; Munechika Enjoji; Hajime Nawata
Arg-Gly-Asp (RGD) peptide ameliorates carbon tetrachloride-induced liver fibrosis via inhibition of collagen production and acceleration of collagenase activity.
International journal of molecular medicine 2004;14(6):1049-53.
2004: Satoru Tsuruta; Makoto Nakamuta; Munechika Enjoji; Kazuhiro Kotoh; Ken-ichi Hiasa; Kensuke Egashira; Hajime Nawata
Anti-monocyte chemoattractant protein-1 gene therapy prevents dimethylnitrosamine-induced hepatic fibrosis in rats.
International journal of molecular medicine 2004;14(5):837-42.
2004: Rie Sugimoto; Munechika Enjoji; Kazuhiro Kotoh; Ken-ichi Noguchi; Satoru Tsuruta; Makoto Nakamuta; Hajime Nawata
[Effect of lamivudine for hepatitis B virus reactivation in blood cancer patients undergoing immunosuppressive chemotherapy].
Fukuoka igaku zasshi = Hukuoka acta medica 2004;95(10):274-9.
2004: Munechika Enjoji; Makoto Nakamuta; Eiichirou Arimura; Shusuke Morizono; Masami Kuniyoshi; Marie Fukushima; Kazuhiro Kotoh; Hajime Nawata
Clinical significance of urinary N1,N12-diacetylspermine levels in patients with hepatocellular carcinoma.
The International journal of biological markers 2004;19(4):322-7.
2004: Munechika Enjoji; Makoto Nakamuta; Koji Yamaguchi; Kazuhiro Kotoh; Shusuke Morizono; Eiichirou Arimura; Marie Fukushima; Masami Kuniyoshi; Manabu Nakashima; Masao Tanaka; Hajime Nawata
RCAS1, a useful serum marker to predict the recurrence of cancer: two cases of cholangiocarcinoma and pancreatic cancer.
Digestive diseases and sciences 2004;49(10):1654-6.
2004: Munechika Enjoji; Koji Yamaguchi; Makoto Nakamuta; Manabu Nakashima; Kazuhiro Kotoh; Masao Tanaka; Hajime Nawata; Takeshi Watanabe
Movement of a novel serum tumour marker, RCAS1, in patients with biliary diseases.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2004;36(9):622-7.
2004: Eiichirou Arimura; Makoto Nakamuta; Kazuhiro Kotoh; Shusuke Morizono; Marie Fukutomi; Satoshi Ohta; Munechika Enjoji; Hironori Sakai; Hajime Nawata
[Evaluation of prognosis and recurrence of hepatocellular carcinoma treated from 1988 to 2002 at Department of Medicine III, Kyushu University Hospital].
Fukuoka igaku zasshi = Hukuoka acta medica 2004;95(8):195-200.
2004: Jun Hayashi; Norihiro Furusyo; Makoto Nakamuta; Mitsuo Shimada
[Mechanism of hepatitis B surface antigen disappearance from and reappearance in the serum of patients with chronic HBV infection].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 8():106-11.
2004: Munechika Enjoji; Koji Yamaguchi; Manabu Nakashima; Satoshi Ohta; Kazuhiro Kotoh; Marie Fukushima; Masami Kuniyoshi; Masao Tanaka; Makoto Nakamuta; Takeshi Watanabe; Hajime Nawata
Serum levels of soluble molecules associated with evasion of immune surveillance: a study in biliary disease.
Liver international : official journal of the International Association for the Study of the Liver 2004;24(4):330-4.
2004: Shusuke Morizono; Makoto Nakamuta; Satoshi Ohta; Marie Fukushima; Kazuhiro Kotoh; Munechika Enjoji; Hajime Nawata
[Case of NASH exacerbated after testectomy due to seminoma].
Fukuoka igaku zasshi = Hukuoka acta medica 2004;95(6):146-51.
2004: Kazufumi Dohmen; Toshihiko Mizuta; Makoto Nakamuta; Naoya Shimohashi; Hiromi Ishibashi; Kyosuke Yamamoto
Fenofibrate for patients with asymptomatic primary biliary cirrhosis.
World journal of gastroenterology : WJG 2004;10(6):894-8.
2004: Munechika Enjoji; Makoto Nakamuta; Hajime Nawata
Oncogenes in tumors of gallbladder and biliary tract.
Fukuoka igaku zasshi = Hukuoka acta medica 2004;95(2):31-5.
2003: Hironobu Watanabe; Munechika Enjoji; Manabu Nakashima; Ken-ichi Noguchi; Naoko Kinukawa; Rie Sugimoto; Kazuhiro Kotoh; Makoto Nakamuta; Hajime Nawata; Takeshi Watanabe
Clinical significance of serum RCAS1 levels detected by monoclonal antibody 22-1-1 in patients with cholangiocellular carcinoma.
Journal of hepatology 2003;39(4):559-63.
2003: Yukio Sonoda; Koji Yamaguchi; Eishi Nagai; Makoto Nakamuta; Tetsuhide Ito; Takashi Eguchi; Kazuo Chijiiwa; Masao Tanaka
Small cell carcinoma of the cystic duct: a case report.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2003;7(5):631-4.
2002: Hideki Ijichi; Mitsuo Shimada; Taketoshi Suehiro; Yuji Soejima; Yoshihiko Maehara; Makoto Nakamuta; Hajime Nawata
[Living donor liver transplantation for a patient with renal failure].
Fukuoka igaku zasshi = Hukuoka acta medica 2002;93(12):266-71.
2002: Taketoshi Suehiro; Mitsuo Shimada; Keiji Kishikawa; Yuji Soejima; Tomoharu Yoshizumi; Yoshihiko Maehara; Rie Nakao; Kazuhiro Hayashida; Makoto Nakamuta; Hiroshi Honda; Kazuo Irita; Kenji Kodama; Shoichi Inaba; Takuro Taniyama
[Living donor liver transplantation for fulminant hepatic failure--medical treatment organization in Kyushu University].
Fukuoka igaku zasshi = Hukuoka acta medica 2002;93(8):141-52.
2002: Munechika Enjoji; Manabu Nakashima; Hidehiro Nishi; Ilseung Choi; Hideki Oimomi; Rie Sugimoto; Kazuhiro Kotoh; Ken ichi Taguchi; Makoto Nakamuta; Hajime Nawata; Takeshi Watanabe
The tumor-associated antigen, RCAS1, can be expressed in immune-mediated diseases as well as in carcinomas of biliary tract.
Journal of hepatology 2002;36(6):786-92.
2002: Munechika Enjoji; Makoto Nakamuta; Masataka Iwao; Rie Sugimoto; Kazuhiro Kotoh; Hajime Nawata; Hironori Sakai
Leptin response in patients undergoing interferon therapy.
Journal of clinical gastroenterology 2002;34(3):287-8.
2002: Makoto Nakamuta; Munechika Enjoji; Koutaro Uchimura; Satoshi Ohta; Rie Sugimoto; Kazuhiro Kotoh; Masaki Kato; Takashi Irie; Tatsushi Muta; Hajime Nawata
Bisphenol a diglycidyl ether (BADGE) suppresses tumor necrosis factor-alpha production as a PPARgamma agonist in the murine macrophage-like cell line, RAW 264.7.
Cell biology international 2002;26(3):235-41.
2002: Satoru Tsuruta; Munechika Enjoji; Makoto Nakamuta; Tetsuji Makihata; Kazuhiro Kotoh; Hironori Sakai; Bun-Ei Ando; Hajime Nawata
Primary hepatic lymphoma in a patient with Sjögren's syndrome.
Journal of gastroenterology 2002;37(2):129-32.
2001: Makoto Nakamuta; Satoshi Ohta; S Tada; Satoru Tsuruta; Rie Sugimoto; Kazuhiro Kotoh; Masaki Kato; Y Nakashima; Munechika Enjoji; Hajime Nawata
Dimethyl sulfoxide inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.
International journal of molecular medicine 2001;8(5):553-60.
2001: Masataka Iwao; Makoto Nakamuta; Munechika Enjoji; H Kubo; T Fukutomi; Y Tanabe; H Nishi; K I Taguchi; Kazuhiro Kotoh; Hajime Nawata
Primary hepatic carcinoid tumor: case report and review of 53 cases.
Medical science monitor : international medical journal of experimental and clinical research 2001;7(4):746-50.
2001: S Tada; Makoto Nakamuta; Munechika Enjoji; Rie Sugimoto; H Iwamoto; Masaki Kato; Y Nakashima; Hajime Nawata
Pirfenidone inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.
Clinical and experimental pharmacology & physiology 2001;28(7):522-7.
2001: K Uchimura; Makoto Nakamuta; M Osoegawa; S Takeaki; H Nishi; H Iwamoto; Munechika Enjoji; Hajime Nawata
Hepatic epithelioid hemangioendothelioma.
Journal of clinical gastroenterology 2001;32(5):431-4.
2001: S Tada; H Iwamoto; Makoto Nakamuta; Rie Sugimoto; Munechika Enjoji; Y Nakashima; Hajime Nawata
A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats.
Journal of hepatology 2001;34(4):529-36.
2001: Makoto Nakamuta; S Tada; K Uchimura; Munechika Enjoji; N Kinukawa; H Iwamoto; R Sugimoto; Mitsuo Shimada; M Ohashi; Keishi Sugimachi; Hajime Nawata
Serum leptin levels in patients with nonalcoholic chronic liver disease.
Hepato-gastroenterology 2001;48(38):527-32.
2001: Marie Fukutomi; Munechika Enjoji; Haruo Iguchi; Masaki Yokota; H Iwamoto; Makoto Nakamuta; Hironori Sakai; Hajime Nawata
Telomerase activity is repressed during differentiation along the hepatocytic and biliary epithelial lineages: verification on immortal cell lines from the same origin.
Cell biochemistry and function 2001;19(1):65-8.
2001: T Koyanagi; Makoto Nakamuta; Munechika Enjoji; H Iwamoto; K Motomura; Hironori Sakai; Hajime Nawata
The selenoorganic compound ebselen suppresses liver injury induced by Propionibacterium acnes and lipopolysaccharide in rats.
International journal of molecular medicine 2001;7(3):321-7.
2001: M Kuniyoshi; Makoto Nakamuta; Hironori Sakai; Munechika Enjoji; N Kinukawa; Kazuhiro Kotoh; Marie Fukutomi; Masaki Yokota; H Nishi; H Iwamoto; N Uike; J Nishimura; S Inaba; Y Maeda; Hajime Nawata; K Muta
Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma.
Journal of gastroenterology and hepatology 2001;16(2):215-9.
2001: Makoto Nakamuta; T Fukutomi; Naoya Shimohashi; N Kinukawa; Koutaro Uchimura; S Tada; K Motomura; Munechika Enjoji; M Kato; H Iwamoto; Y Tanabe; Y Imari; S Sakamoto; Hironori Sakai; Hajime Nawata
Kinetics of the hepatitis C virus during interferon therapy as a marker of therapeutic response.
Journal of gastroenterology and hepatology 2001;16(1):29-33.
2001: Koutaro Uchimura; Makoto Nakamuta; Munechika Enjoji; T Irie; Rie Sugimoto; T Muta; H Iwamoto; Hajime Nawata
Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells.
Hepatology (Baltimore, Md.) 2001;33(1):91-9.
2000: T Koyanagi; Makoto Nakamuta; H Sakai; Rie Sugimoto; Munechika Enjoji; K Koto; H Iwamoto; T Kumazawa; M Mukaide; Hajime Nawata
Analysis of HBs antigen negative variant of hepatitis B virus: unique substitutions, Glu129 to Asp and Gly145 to Ala in the surface antigen gene.
Medical science monitor : international medical journal of experimental and clinical research 2000;6(6):1165-9.
2000: F Ishikawa; Makoto Nakamuta; M Kato; H Iwamoto; Munechika Enjoji; Y Miyata; Toyoshi Inoguchi; Hironori Sakai; Hajime Nawata
Reversibility of serum NH3 level in a case of sudden onset and rapidly progressive case of type 2 citrullinemia.
Internal medicine (Tokyo, Japan) 2000;39(11):925-9.
2000: Munechika Enjoji; Makoto Nakamuta; Naoko Kinukawa; Rie Sugimoto; K Noguchi; Satoru Tsuruta; Masataka Iwao; Kazuhiro Kotoh; H Iwamoto; Hajime Nawata
Beta-lipoproteins influence the serum level of hepatitis C virus.
Medical science monitor : international medical journal of experimental and clinical research 2000;6(5):841-4.
2000: Naoya Shimohashi; Makoto Nakamuta; Koutaro Uchimura; Rie Sugimoto; H Iwamoto; Munechika Enjoji; Hajime Nawata
Selenoorganic compound, ebselen, inhibits nitric oxide and tumor necrosis factor-alpha production by the modulation of jun-N-terminal kinase and the NF-kappab signaling pathway in rat Kupffer cells.
Journal of cellular biochemistry 2000;78(4):595-606.
2000: H Iwamoto; Makoto Nakamuta; S Tada; Rie Sugimoto; Munechika Enjoji; Hajime Nawata
A p160ROCK-specific inhibitor, Y-27632, attenuates rat hepatic stellate cell growth.
Journal of hepatology 2000;32(5):762-70.
2000: H Iwamoto; Makoto Nakamuta; S Tada; R Sugimoto; Munechika Enjoji; H Nawata
Platelet-derived growth factor receptor tyrosine kinase inhibitor AG1295 attenuates rat hepatic stellate cell growth.
The Journal of laboratory and clinical medicine 2000;135(5):406-12.
2000: Munechika Enjoji; Manabu Nakashima; Makoto Nakamuta; Hajime Nawata
Transforming growth factor-alpha induces the differentiation of sarcomatoid cholangiocarcinoma cells.
Japanese journal of cancer research : Gann 2000;91(2):223-30.
1999: N Higashi; Makoto Nakamuta; K Motomura; M Enjoji; H Sakai; H Nawata
Serum level of interleukin-4 is a possible marker of therapeutic response to interferon treatment in patients with chronic hepatitis C.
Journal of hepatology 1999;31(2):383.
1999: M Kato; H Iwamoto; N Higashi; Rie Sugimoto; Koutaro Uchimura; S Tada; H Sakai; Makoto Nakamuta; Hajime Nawata
Role of Rho small GTP binding protein in the regulation of actin cytoskeleton in hepatic stellate cells.
Journal of hepatology 1999;31(1):91-9.
1999: H Iwamoto; H Sakai; S Tada; Makoto Nakamuta; H Nawata
Induction of apoptosis in rat hepatic stellate cells by disruption of integrin-mediated cell adhesion.
The Journal of laboratory and clinical medicine 1999;134(1):83-9.
1999: H Iwamoto; Hironori Sakai; Kazuhiro Kotoh; Makoto Nakamuta; Hajime Nawata
Soluble Arg-Gly-Asp peptides reduce collagen accumulation in cultured rat hepatic stellate cells.
Digestive diseases and sciences 1999;44(5):1038-45.
1995: Makoto Nakamuta; M Ohashi; T Fukutomi; Y Tanabe; K Hiroshige; Hajime Nawata
Rise of plasma myeloperoxidase during interferon therapy.
Journal of gastroenterology and hepatology 1995;10(3):277-80.
1994: Makoto Nakamuta; M Ohashi; T Fukutomi; Y Tanabe; K Hiroshige; O Nakashima; Hajime Nawata
Oral contraceptive-dependent growth of focal nodular hyperplasia.
Journal of gastroenterology and hepatology 1994;9(5):521-3.
1994: Makoto Nakamuta; Y Tanabe; M Ohashi; K Yoshida; K Hiroshige; Hajime Nawata
Unique imagings of CT and MR in liver metastasis from gastric leiomyosarcoma.
Fukuoka igaku zasshi = Hukuoka acta medica 1994;85(6):195-8.
1994: Makoto Nakamuta; M Ohashi; K Goto; Y Tanabe; K Hiroshige; H Nawata
The re-evaluation of sex steroids metabolism in patients with non-alcoholic liver cirrhosis.
Fukuoka igaku zasshi = Hukuoka acta medica 1994;85(6):187-94.
1994: Makoto Nakamuta; S Sakamoto; Y Miyata; M Sato; Hajime Nawata
Benign recurrent intrahepatic cholestasis: a long-term follow-up.
Hepato-gastroenterology 1994;41(3):287-9.
1993: Makoto Nakamuta; M Ohashi; Y Tanabe; K Hiroshige; Hajime Nawata
High plasma concentration of myeloperoxidase in cirrhosis: a possible marker of hypersplenism.
Hepatology (Baltimore, Md.) 1993;18(6):1377-83.
1993: Makoto Nakamuta; Y Tanabe; M Ohashi; K Yoshida; K Hiroshige; Hajime Nawata
Transabdominal seeding of hepatocellular carcinoma after fine-needle aspiration biopsy.
Journal of clinical ultrasound : JCU 1993;21(8):551-6.
1993: Makoto Nakamuta; M Ohashi; K Goto; Y Tanabe; K Hiroshige; Hajime Nawata
Diabetes mellitus-associated glycogen storage hepatomegaly: report of a case and review of the Japanese literature.
Fukuoka igaku zasshi = Hukuoka acta medica 1993;84(7):354-8.
1993: Makoto Nakamuta; M Ohashi; S Tabata; Y Tanabe; K Goto; M Naruse; K Naruse; K Hiroshige; Hajime Nawata
High plasma concentrations of endothelin-like immunoreactivities in patients with hepatocellular carcinoma.
The American journal of gastroenterology 1993;88(2):248-52.
1992: Makoto Nakamuta; T Sugimura; K Kotoh; T Fukutomi; S Sakamoto; M Yamamoto; Hajime Nawata
Anti-tolA antibody in non-A, non-B chronic liver disease.
Fukuoka igaku zasshi = Hukuoka acta medica 1992;83(10):367-76.
1992: Ryoichi Takayanagi; K Ohnaka; Y Sakai; R Nakao; Toshihiko Yanase; M Haji; T Inagami; H Furuta; D F Gou; Makoto Nakamuta
Molecular cloning, sequence analysis and expression of a cDNA encoding human type-1 angiotensin II receptor.
Biochemical and biophysical research communications 1992;183(2):910-6.
1992: T Fukutomi; Y Shinomiya; H Iwamoto; H Isobe; Makoto Nakamuta; Hironori Sakai; B Ando; S Sakamoto; Hajime Nawata
[A case of simple hepatic cyst accompanied with dilatation of the intrahepatic bile duct].
Fukuoka igaku zasshi = Hukuoka acta medica 1992;83(3):134-8.
1991: Makoto Nakamuta; Ryoichi Takayanagi; Y Sakai; S Sakamoto; H Hagiwara; T Mizuno; Y Saito; S Hirose; M Yamamoto; Hajime Nawata
Cloning and sequence analysis of a cDNA encoding human non-selective type of endothelin receptor.
Biochemical and biophysical research communications 1991;177(1):34-9.
1991: H Isobe; Y Nishi; T Fukutomi; H Iwamoto; Makoto Nakamuta; Hironori Sakai; B Andoh; S Sakamoto; Hajime Nawata
Inflammatory pseudotumor of the liver associated with acute myelomonocytic leukemia.
The American journal of gastroenterology 1991;86(2):238-40.
1989: Makoto Nakamuta; M Furuich; K Takahashi; N Suzuki; H Endo; M Yamamoto
Isolation and characterization of a family of rat endogenous retroviral sequences.
Virus genes 1989;3(1):69-83.